Ghrelin: a new treatment for non-alcoholic fatty liver disease?


Li et al. [1] report in this issue of the journal that administration of ghrelin might improve inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development (NAFLD). Non-alcoholic fatty liver disease development is becoming an increasingly important disease condition [2], as NAFLD and non-alcoholic… (More)
DOI: 10.1007/s12020-012-9800-2


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics